JP2023511382A5 - - Google Patents

Info

Publication number
JP2023511382A5
JP2023511382A5 JP2022544318A JP2022544318A JP2023511382A5 JP 2023511382 A5 JP2023511382 A5 JP 2023511382A5 JP 2022544318 A JP2022544318 A JP 2022544318A JP 2022544318 A JP2022544318 A JP 2022544318A JP 2023511382 A5 JP2023511382 A5 JP 2023511382A5
Authority
JP
Japan
Application number
JP2022544318A
Other languages
Japanese (ja)
Other versions
JP2023511382A (ja
JPWO2021150570A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/014129 external-priority patent/WO2021150570A1/en
Publication of JP2023511382A publication Critical patent/JP2023511382A/ja
Publication of JPWO2021150570A5 publication Critical patent/JPWO2021150570A5/ja
Publication of JP2023511382A5 publication Critical patent/JP2023511382A5/ja
Pending legal-status Critical Current

Links

JP2022544318A 2020-01-22 2021-01-20 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療 Pending JP2023511382A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062964351P 2020-01-22 2020-01-22
US62/964,351 2020-01-22
US202063086145P 2020-10-01 2020-10-01
US63/086,145 2020-10-01
PCT/US2021/014129 WO2021150570A1 (en) 2020-01-22 2021-01-20 Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)

Publications (3)

Publication Number Publication Date
JP2023511382A JP2023511382A (ja) 2023-03-17
JPWO2021150570A5 JPWO2021150570A5 (https=) 2024-02-16
JP2023511382A5 true JP2023511382A5 (https=) 2024-02-16

Family

ID=74592808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544318A Pending JP2023511382A (ja) 2020-01-22 2021-01-20 完全ヒトグリコシル化ヒトα-L-イズロニダーゼ(IDUA)を用いたムコ多糖症I型の治療

Country Status (9)

Country Link
US (1) US20230059395A1 (https=)
EP (1) EP4093428A1 (https=)
JP (1) JP2023511382A (https=)
KR (1) KR20220131522A (https=)
AU (1) AU2021211416A1 (https=)
BR (1) BR112022014563A2 (https=)
CA (1) CA3167685A1 (https=)
IL (1) IL294625A (https=)
WO (1) WO2021150570A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA50016A (fr) 2017-07-06 2020-07-08 Univ Pennsylvania Thérapie génique médiée par aav9 pour traiter la mucopolysaccharidose de type i
TWI835747B (zh) 2017-09-22 2024-03-21 賓州大學委員會 用於治療黏多醣病 ii 型之基因治療
CA3167741A1 (en) * 2020-01-29 2021-08-05 Regenxbio Inc. Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cells

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1916258E (pt) 1999-08-09 2014-07-29 Genzyme Corp Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia
NZ532635A (en) 2001-11-13 2007-05-31 Univ Pennsylvania A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
CN1856576B (zh) 2003-09-30 2011-05-04 宾夕法尼亚州立大学托管会 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
WO2006110689A2 (en) 2005-04-07 2006-10-19 The Trustees Of The University Of Pennsylvania Method of increasing the function of an aav vector
EP1777906A1 (en) 2005-06-09 2007-04-25 Matsushita Electric Industrial Co., Ltd. Amplitude error compensating apparatus and orthogonality error compensating apparatus
WO2010138263A2 (en) 2009-05-28 2010-12-02 University Of Massachusetts Novel aav 's and uses thereof
US8628966B2 (en) 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
EP2634253B1 (en) 2010-10-27 2016-05-11 Jichi Medical University Adeno-associated virus virions for transferring genes into neural cells
WO2012109570A1 (en) 2011-02-10 2012-08-16 The University Of North Carolina At Chapel Hill Viral vectors with modified transduction profiles and methods of making and using the same
HRP20171334T1 (hr) 2011-04-22 2017-11-17 The Regents Of The University Of California Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe
ES2857773T5 (es) 2011-08-24 2024-06-04 Univ Leland Stanford Junior Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos
WO2013170078A1 (en) 2012-05-09 2013-11-14 Oregon Health & Science University Adeno associated virus plasmids and vectors
EP2970946A4 (en) 2013-03-13 2016-09-07 Philadelphia Children Hospital ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF
US9585971B2 (en) 2013-09-13 2017-03-07 California Institute Of Technology Recombinant AAV capsid protein
HUE052676T2 (hu) 2013-10-11 2021-05-28 Massachusetts Eye & Ear Infirmary Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik
WO2015164757A1 (en) 2014-04-25 2015-10-29 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
EP3411488A1 (en) * 2016-02-03 2018-12-12 The Trustees Of The University Of Pennsylvania Gene therapy for treating mucopolysaccharidosis type i
JP7042814B2 (ja) * 2016-11-01 2022-03-28 日本光電工業株式会社 患者の頭部に配置されて当該患者の脳の皮質組織の脈動を測定するためのトランスデューサを含むシステム
EP3541946A1 (en) * 2016-11-15 2019-09-25 Regents Of The University Of Minnesota Method for improving neurological function in mpsi and mpsii and other neurological disorders
CA3049915A1 (en) * 2017-01-31 2018-08-09 Stephen YOO Treatment of mucopolysaccharidosis i with fully-human glycosylated human alpha-l-iduronidase (idua)
MA50016A (fr) * 2017-07-06 2020-07-08 Univ Pennsylvania Thérapie génique médiée par aav9 pour traiter la mucopolysaccharidose de type i

Similar Documents

Publication Publication Date Title
BR112023012656A2 (https=)
BR112022009896A2 (https=)
JP2023511382A5 (https=)
BR112023011738A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)
BR102021016200A2 (https=)
BR102021015566A2 (https=)
BR102021015450A8 (https=)
BR102021015220A2 (https=)
BR102021015247A2 (https=)
BR102021014044A2 (https=)
BR102021014056A2 (https=)